Fellow of the European Confederation of Medical Mycology (ECMM)
Microbiology, Aspergillosis, Pharmacology, Mycosis and Aspergillus are his primary areas of study. His In vivo research extends to Microbiology, which is thematically connected. His biological study spans a wide range of topics, including Cancer, Amphotericin B and Gliotoxin.
The Pharmacology study which covers Caspofungin that intersects with In vitro and Calcineurin. He interconnects Aspergillus fumigatus, Intensive care medicine and Pathology in the investigation of issues within Mycosis. His work in Aspergillus addresses issues such as Azole, which are connected to fields such as Zygomycosis, Minimum inhibitory concentration and Mucormycosis.
His scientific interests lie mostly in Microbiology, Pharmacology, Fluconazole, Voriconazole and Caspofungin. Antifungal is closely connected to In vitro in his research, which is encompassed under the umbrella topic of Microbiology. His research in Pharmacology intersects with topics in Potency and In vivo.
He works mostly in the field of Fluconazole, limiting it down to concerns involving Cryptococcus neoformans and, occasionally, Cryptococcosis. His work deals with themes such as Itraconazole, Aspergillosis and Lung, which intersect with Voriconazole. His Aspergillosis study incorporates themes from Aspergillus fumigatus, Mycosis and Aspergillus.
Nathan P. Wiederhold mainly investigates Microbiology, Fluconazole, Posaconazole, In vivo and Voriconazole. His research on Microbiology frequently connects to adjacent areas such as Fusarium. His Fluconazole research is multidisciplinary, incorporating perspectives in Coccidioides immitis, Azole, Candida auris and Candida albicans.
His Azole research integrates issues from Aspergillus fumigatus and Aspergillosis. His work in In vivo covers topics such as Pharmacology which are related to areas like Kidney. His Voriconazole research includes elements of Itraconazole, Terbinafine and Myeloid leukemia.
The scientist’s investigation covers issues in Microbiology, Caspofungin, In vivo, Fluconazole and Posaconazole. Many of his studies on Microbiology involve topics that are commonly interrelated, such as Aspergillosis. His Caspofungin research is multidisciplinary, relying on both Intraperitoneal injection, Candida glabrata, Echinocandin and Kidney.
His research integrates issues of Inoculation, In vitro, Central nervous system, Coccidioides immitis and Pharmacology in his study of In vivo. The various areas that Nathan P. Wiederhold examines in his Fluconazole study include Candida auris and Candida albicans. His Posaconazole research incorporates elements of Aspergillus, Amphotericin B deoxycholate, Guideline, Disease management and Rare disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Oliver A. Cornely;Ana Alastruey-Izquierdo;Dorothee Arenz;Sharon C. A. Chen.
Lancet Infectious Diseases (2019)
Antifungal resistance: current trends and future strategies to combat.
Nathan P Wiederhold.
Infection and Drug Resistance (2017)
Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration-Dependent Activity
Nathan P. Wiederhold;Dimitrios P. Kontoyiannis;Dimitrios P. Kontoyiannis;Jingduan Chi;Randall A. Prince;Randall A. Prince.
The Journal of Infectious Diseases (2004)
Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa
Vincent H. Tam;Amy N. Schilling;Giao Vo;Samer Kabbara.
Antimicrobial Agents and Chemotherapy (2005)
Fungal Planet description sheets: 320–370
P. W. Crous;M. J. Wingfield;J. Guarro;M. Hernández-Restrepo.
Detection of Gliotoxin in Experimental and Human Aspergillosis
Russell E. Lewis;Russell E. Lewis;Nathan P. Wiederhold;Nathan P. Wiederhold;Jingduan Chi;Xiang-Yang Han.
Infection and Immunity (2005)
Fungal Planet description sheets: 469-557
Pedro W. Crous;Pedro W. Crous;Michael J. Wingfield;Treena I. Burgess;G. E.St J. Hardy.
Fungal Planet description sheets: 400–468
P. W. Crous;P. W. Crous;M. J. Wingfield;D. M. Richardson;J. J. Le Roux.
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy.
Nathan P Wiederhold;Russell E Lewis.
Expert Opinion on Investigational Drugs (2003)
Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
George Richard Thompson;Nathan P. Wiederhold;Nathan P. Wiederhold;Ana C. Vallor;Nyria C. Villareal.
Antimicrobial Agents and Chemotherapy (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: